The socioeconomic burden of hidradenitis suppurativa/acne inversa-Reference-Cited by-同舟云学术

The socioeconomic burden of hidradenitis suppurativa/acne inversa

Published:2019-07 Issue:1 Volume:181 Page:7-8
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Zouboulis C.C.¹^ORCID

Affiliation:

1. Departments of Dermatology, Venereology, Allergology and Immunology Dessau Medical Center Brandenburg Medical School Theodor Fontane Auenweg 38 06847 Dessau Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17396

Reference10 articles.

1. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

2. The Application of Multiple Quality-of-Life Instruments in Individuals with Mild-to-Moderate Psoriasis

3. The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis

4. Hidradenitis suppurativa - characteristics and consequences

5. Hidradenitis suppurativa markedly decreases quality of life and professional activity

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond caregiving: Navigating life with a developmentally disabled daughter with a severe case of Hidradenitis Suppurativa;Skin Health and Disease;2024-06-04

2. S2k‐Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa – Kurzfassung;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06

3. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05-21

4. S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2);Aktuelle Dermatologie;2024-02

5. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States;Advances in Therapy;2023-07-24